AMERICAN INTERNATIONAL GROUP, INC. - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$100,067
-16.8%
18,361
+3.7%
0.00%0.0%
Q2 2023$120,237
+35.4%
17,708
-0.1%
0.00%0.0%
Q1 2023$88,777
+4.8%
17,720
+2.0%
0.00%0.0%
Q4 2022$84,746
-66.2%
17,366
-0.4%
0.00%
-50.0%
Q3 2022$251,000
-3.5%
17,430
+1.4%
0.00%0.0%
Q2 2022$260,000
+26.2%
17,184
-1.0%
0.00%
+100.0%
Q1 2022$206,000
-31.6%
17,350
-6.6%
0.00%
-50.0%
Q4 2021$301,000
-44.9%
18,572
-2.9%
0.00%
-33.3%
Q3 2021$546,000
-17.5%
19,128
-2.3%
0.00%
+50.0%
Q2 2021$662,000
+23.0%
19,582
+10.1%
0.00%0.0%
Q1 2021$538,000
-38.7%
17,783
+0.3%
0.00%
-33.3%
Q4 2020$878,000
+27.8%
17,736
-0.9%
0.00%0.0%
Q3 2020$687,000
-13.1%
17,905
-2.2%
0.00%
-25.0%
Q2 2020$791,000
+116.7%
18,311
+30.8%
0.00%
+100.0%
Q1 2020$365,000
-21.2%
13,995
-5.5%
0.00%0.0%
Q4 2019$463,000
+38.2%
14,805
+15.2%
0.00%
+100.0%
Q3 2019$335,000
+13.2%
12,850
-0.7%
0.00%0.0%
Q2 2019$296,000
+155.2%
12,939
+191.4%
0.00%
Q1 2019$116,000
+24.7%
4,441
-3.1%
0.00%
Q4 2018$93,0004,5850.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$2,271,0002.63%
Sofinnova Investments, Inc. 2,194,278$26,068,0001.98%
MPM BioImpact LLC 443,702$5,271,0001.42%
Soleus Capital Management, L.P. 238,982$2,839,0000.37%
Lombard Odier Asset Management (Switzerland) SA 221,774$2,635,0000.21%
Artal Group S.A. 400,000$4,752,0000.20%
Polar Capital Holdings Plc 2,877,671$34,187,0000.15%
ASHFORD CAPITAL MANAGEMENT INC 106,770$1,268,0000.14%
Cormorant Asset Management, LP 150,000$1,782,0000.14%
Virtus ETF Advisers LLC 23,646$281,0000.13%
View complete list of Y-MABS THERAPEUTICS INC shareholders